Biopsy Clips: Why a Tiny Marker Stays Behind
SaveA biopsy clip is a tiny titanium marker, about 1 to 2 mm wide, left to flag exactly where your breast tissue was sampled. It helps future mammograms, ultrasound, or any surgery locate the same spot. Placing a marker is routine, it does not mean cancer was found, and most people never feel it.
Last updated: July 2026
Why is a marker placed at all?
Marking the biopsy site solves a practical problem: once the tiny amount of tissue is removed and any bruising heals, the exact spot can become invisible on later imaging. A clip lets a radiologist line up next year's mammogram against this year's or guide a surgeon straight to the site if more tissue is ever needed.
According to breast-screening guidance, this correlation between old and new imaging is central to safe follow-up 1Ref 1American College of Obstetricians and Gynecologists (2017).Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women.ACOG breast-screening bulletin supporting that a marker is routinely placed to correlate imaging over time and that most biopsies are benign.. Because most biopsies are benign, and fewer than 1 in 5 find cancer, the marker usually just anchors routine screening.
Is the clip safe for MRI and airport security?
Modern biopsy clips are made of titanium or a titanium-nickel blend chosen specifically to be MRI-compatible. They will not set off airport metal detectors, and they are far too small to trigger a body scanner.
An MRI can be performed safely with a clip in place, though it may create a small, harmless signal void that radiologists recognize. Tissue markers are designed for long-term imaging follow-up, and some clips dissolve their outer gel or pellet over about 3 to 6 months while the metal core stays put.
Can a biopsy clip move or cause problems?
A placed clip can shift a few millimeters in the first hours as the breast tissue that was compressed during the biopsy relaxes - an effect radiologists call the accordion effect. After that early settling, it stays put in the vast majority of cases.
Reactions are rare, and fewer than 1 in 100 people have any sensitivity to the metal. The marker itself does not need removal and causes no ongoing symptoms in the vast majority of people. Persistent pain, swelling, or skin changes at the site would still be worth raising with your clinician.
Will the clip affect future mammograms or care?
Far from interfering, the clip makes future breast care easier. On a mammogram it appears as a small distinct shape - sometimes a ribbon, coil, or tiny bar - that tells the radiologist precisely where you were biopsied and what the result was.
If you change clinics, the marker travels with you and keeps your imaging history connected across future mammograms. According to well-woman guidance, keeping your biopsy and pathology reports helps the next team read the marker correctly 3Ref 3American College of Obstetricians and Gynecologists (2018).ACOG Committee Opinion No. 755: Well-Woman Visit.ACOG well-woman guidance supporting that keeping biopsy and pathology records aids ongoing breast screening and clinician follow-up.. Breast density, present in nearly half of women at about 40 to 50 percent and higher before the menopausal transition, is one reason a durable marker is so useful on dense films 2Ref 2National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025).Breast Cancer Screening.NCI patient screening summary supporting breast-density prevalence (roughly 40-50% of women) and that dense tissue makes imaging harder to read, which is why a durable marker helps..
When a biopsy marker needs your clinician's attention
A biopsy clip almost never needs action, but a few situations warrant a call to your clinician. New, persistent pain at the site or visible skin changes deserve review, as does any question about whether a marker is compatible with a planned MRI.
Bring the details of your biopsy - the date, the clip type if you know it, and your pathology report - to that visit, and mention any breast lump that grows afterward. According to breast-screening guidance, most markers simply support your ongoing breast screening without any intervention 1Ref 1American College of Obstetricians and Gynecologists (2017).Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women.ACOG breast-screening bulletin supporting that a marker is routinely placed to correlate imaging over time and that most biopsies are benign.. Gale can help you keep those records in one place.
Common questions
Related
Breast health
Mammograms in Pregnancy: When They're NeededBreast health
Dense Breasts: Do You Need More Than a Mammogram?Breast health
Breasts After Menopause: Softer, Different, Normal
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When a biopsy marker needs attention
- —New, persistent pain at the biopsy site weeks later is a reason to contact your clinician.
- —Skin changes, swelling, or a growing lump over the marker is a reason to seek clinician review.
- —Any question about whether your clip is safe for a planned MRI is a reason to tell the imaging team before the scan.
- —Signs of infection at the site, such as spreading redness or fever, are a reason to call your care team promptly.
This article is general health education, not medical advice. Questions about your specific biopsy marker and imaging are best answered by the radiologist or breast surgeon who placed it and your primary clinician.
References
- 1.American College of Obstetricians and Gynecologists (2017). Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002158 ✓ACOG breast-screening bulletin supporting that a marker is routinely placed to correlate imaging over time and that most biopsies are benign.
- 2.National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025). Breast Cancer Screening. National Cancer Institute (NCI), NIH. link ✓NCI patient screening summary supporting breast-density prevalence (roughly 40-50% of women) and that dense tissue makes imaging harder to read, which is why a durable marker helps.
- 3.American College of Obstetricians and Gynecologists (2018). ACOG Committee Opinion No. 755: Well-Woman Visit. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002897 ✓ACOG well-woman guidance supporting that keeping biopsy and pathology records aids ongoing breast screening and clinician follow-up.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy